Cardiac ion channels and transport processes

Cardiac ion channels and transport processes represent a broad functional grouping of various proteins, including voltage-gated ion channels and active transporters, that collectively regulate the electrical and mechanical activity of the heart. This category is not a single molecular entity but rather a classification used in pharmacological databases to describe drugs or assays that affect multiple components of the cardiac electrophysiological machinery (PubMed: 11850320). Key components within this group include sodium (Na+), potassium (K+), and calcium (Ca2+) channels, as well as the Na+/K+-ATPase pump and the sodium-calcium exchanger, which are essential for the cardiac action potential and excitation-contraction coupling (StatPearls: NBK526062). Drugs interacting with this non-specific group, such as Class I and Class III antiarrhythmics, often exhibit polypharmacology by modulating several ion currents simultaneously to stabilize heart rhythm (PubChem: CID 2157). However, because these processes are fundamental to life-sustaining cardiac function, non-specific modulation carries a high risk of adverse effects, including the induction of life-threatening arrhythmias like Torsades de Pointes (StatPearls: NBK532945). Consequently, therapeutic agents in this category require intensive monitoring of electrocardiographic parameters and electrolyte balance to ensure patient safety.

Other names

Cardiac electrophysiology targetsMyocardial ion channels and transportersCardiac ion flux proteinsCardiac ion transport systems

Modulation of ion conductance (sodium, potassium, calcium) and active transport (Na+/K+-ATPase) across the myocardial sarcolemma to regulate electrical excitability and contractility.